Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer

BACKGROUND: CD47 has high levels of expression in malignant cancer cells, which binds to SIRP-α to release the “don't eat me” signal and prevents mononuclear macrophages from phagocytosing the cells. Resistance to drugs and metastases are potential barriers for prostate cancer endocrine therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qianqian, Feng, Chunxaing, Chen, Yuchun, Peng, Tianming, Li, Yong, Wu, Kunlin, Pu, Xiaoyong, Chen, Hanzhong, Liu, Jiumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505079/
https://www.ncbi.nlm.nih.gov/pubmed/37719086
http://dx.doi.org/10.1155/2023/2473075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505079/
https://www.ncbi.nlm.nih.gov/pubmed/37719086
http://dx.doi.org/10.1155/2023/2473075

Ejemplares similares